RESPIRATORY INFECTION
Clinical trials for RESPIRATORY INFECTION explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY INFECTION trials appear
Sign up with your email to follow new studies for RESPIRATORY INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug AV-001 aims to help hospitalized pneumonia patients breathe easier
Disease control Recruiting nowThis study tests an experimental drug called AV-001 in 120 hospitalized adults with pneumonia who need extra oxygen. The drug is given daily through an IV and compared to a placebo, alongside standard care. The goal is to see if AV-001 is safe and helps patients recover faster fr…
Matched conditions: RESPIRATORY INFECTION
Phase: PHASE2 • Sponsor: Vasomune Therapeutics, Inc. • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New nose swab test aims to spot coronaviruses faster
Diagnosis Recruiting nowThis study evaluates a new test called the BioFire Emerging Coronavirus Panel, which uses leftover nose swab samples to detect coronaviruses, including COVID-19. Researchers will check how accurate and reliable the test is compared to standard methods. About 1,500 samples will be…
Matched conditions: RESPIRATORY INFECTION
Sponsor: BioFire Defense LLC • Aim: Diagnosis
Last updated May 17, 2026 08:51 UTC
-
New pill aims to stop recurring chest infections in adults
Prevention Recruiting nowThis study tests whether a tablet called Buccalin can prevent repeated lower respiratory tract infections (like bronchitis) in adults. About 240 people who have had at least two infections in the past year will take either Buccalin or a placebo for 12 months (3 days each month). …
Matched conditions: RESPIRATORY INFECTION
Phase: PHASE4 • Sponsor: Laboratorio Farmaceutico SIT srl • Aim: Prevention
Last updated May 17, 2026 08:47 UTC